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Abstract 
Purpose: To investigate the anti-proliferative and apoptotic activity of crude and dichloromethane 
fraction of A. sieberi against seven cancer cell lines (Colo20, HCT116, DLD, MCF7, Jurkat, HepG2 and 
L929). 
Methods: A. sieberi was extracted with methanol and further purification was carried out using liquid-
liquid extraction with hexane, dichloromethane and ethyl acetate. Each extract was assayed for 
cytotoxic potential against cancer cell lines using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
Bromide (MTT) assay. The morphology of the HepG2 cell nucleus was investigated by Hoechst 33342, 
DNA-binding dye. A Tali™ image-based cytometer was used to assess cell viability, death and 
apoptosis using annexin-v /pi (propidium iodide). A chromatographic fingerprint was constructed using 
high performance liquid chromatography (HPLC). 
Results: The most effective anticancer activity of the unrefined methanol extract was against HepG2 
cell lines (LC50 = 161.5 µg/mL). The hexane and ethyl acetate fractions showed no antiproliferative 
activity. The dichloromethane fraction displayed higher cytotoxic activity (LC50 = 61.75 µg/mL) and also 
repressed the migration of the cells. About 50 % of HepG2 cells were apoptotic when treated for 24 h 
with the dichloromethane fraction at the concentration of 120 µg/mL  
Conclusion: A. sieberi possesses apoptotic activity and inhibited the migration of the HepG2 cell lines.  
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Plants are considered to be among the main 
natural sources of bioactive chemicals. Millions 
of people believe in the use of plant and herbal 
remedies for almost all ailments [1].  Around 50 
% of the prescriptions in the USA and Europe are 
of natural origin or derived from natural sources 
[2]. In the Middle East region around 700 species 
of known plants are known for their medicinal 
properties [3].  
 
The main factor which contributes to the failure of 
many forms of chemotherapy is drug resistance 
[4]. This resistance means that it is important to 
look for new anticancer agents to bypass the 
resistance mechanisms. Synthetic chemistry has 
traditionally been believed to be the dominant 
method for drug discovery, but using plants with 
medicinal value as a source for unique natural 
products for treatment and disease prevention is 
an increasingly promising route [4].   
 
Artemisia is an extensively distributed genus of 
the Asteraceae family. A. sieberi is a widely 
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distributed perennial shrub in the Middle East 
and Mediterranean regions [6].  Among the 
plants that have been studied in Jordan, A. 
sieberi is recorded to have the highest use value. 
In Jordan, the locals Bedouins traditionally used 
it for the treatment of heart disorders, sexual 
weakness in males, diabetes, stomach ache [7] 
and for the treatment of wounds [8]. In Saudi 
Arabia, Bedouins inhale the smoke produced by 
burning this plant for unspecified medicinal 
properties [9]. A. sieberi has anti-bacterial, 
antioxidant, neurological, anti-spasmodic, 
pesticidal, hypoglycemic and cytotoxic activities. 
[5].   
 
In this article, we partially purified the unrefined 
extract of the aerial parts of A. sieberi using a 
bioassay-guided procedure to explore the 
anticancer potential of the unrefined extract and 





Plant material  
 
The aerial parts of A. sieberia were collected 
from Wadi Hanifa, Riyadh, Kingdom of Saudi 
Arabia, in January 2014. The Identity of the plant  
was authenticated in the Department of Botany 
and Microbiology, College of Science, King Saud 
University, where the specimen was deposited 
(voucher no:132014). 100 g of the aerial parts 
were blended in a Waring blender with 500 mL 
methanol and left to stir overnight at 150 rpm and 
30 °C. This process was repeated three times, 
adding fresh methanol to the remaining residue 
on each occasion. The extract was pooled and 
centrifuged for 10 min at 5000 rpm. The 
supernatant was pooled, dried at 45 °C using a 
rotary evaporator and kept in the freezer until 
use. 
 
Partial purification of the unrefined methanol 
extract by partition in solvents of different 
polarities  
 
The unrefined methanol extract of A. sieberia 
was dissolved in 20 % (v/v) methanol and then a 
similar amount of hexane was added and stirred 
for 5 min. The hexane layer containing the non-
polar compounds was collected. This process 
was repeated twice and the hexane layers were 
pooled and combined, and later evaporated in a 
rotary evaporator at 45 °C. The methanol phase 
was then mixed with a similar volume of 
dichloromethane and the same process was 
repeated as per hexane above. The process was 
repeated with ethyl acetate following the same 
procedure. The fractions were dissolved in 
methanol and used for the tests. 
 
Proliferation and cytotoxicity assays 
 
The seven cancer cell lines selected for the in 
vitro antiproliferative bioactivity screening were 
Colo20, HCT116, DLD (colorectal adeno-
carcinoma). MCF7 (human breast cancer), Jurkat 
(human T lymphocyte), HepG2 (hepatocarci-
noma) and L929 (mouse fibrosarcoma cells). The 
cells were grown in Dulbecco’s modified Eagle’s 
medium (DMEM) complemented with 10 % foetal 
bovine serum in standard 24 well-plates.  In each 
well the cell suspension (1 mL, 105 cells/mL) was 
incubated at 37 ºC for 24 h in 5 % CO2.  Extracts 
were studied for cytotoxic activity using the 3-(4, 
5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium 
bromide (MTT) test. After 24 h of treatment, the 
culture medium was aspirated and fresh DMEM 
medium containing MTT (0.1 mg/mL) was added. 
After 2 h of incubation, this solution was 
aspirated, and the blue formazan formed was 
dissolved in 100 µL of 0.1 % HCl-MeOH. The 
plates were read at 595 nm using a micro plate 
reader (Biochem Ltd, England). 
 
Hoescht 33258 staining  
 
Evaluation of morphological of apoptosis was 
assessed by Hoechst 33258 dye. The cells were 
plated in 6-well tissue culture plates (5 × 104 
cell/mL, 1 mL/well) and following incubation 
overnight, the old medium was substituted with 
fresh medium. The culture medium containing  
the dichloromethane fraction was aspirated, and 
the cells were fixed in 3 % paraformaldehyde for 
20 min. Cells were washed twice with phosphate 
buffer saline (PBS), and subsequently stained 
with 0.1 μg/mL of Hoechst 33258 dye (Life 
Technology, USA) for 15 min in the dark. The 
stained cells were rinsed five times with PBS, 
and were then observed under a fluorescent 




The cells were seeded in a T25 flask and 
incubated with the dichloromethane fraction at a 
concentration of 95 µg/mL. 24 h post-treatment, 
the cells were trypsinized, harvested and stained 
using annexin-V Alexa Fluor® 488/PI (propidium 
iodide), according to the kit instructions (Tali™ 
apoptosis kit, Invitrogen). Cell death, viability and 
apoptosis were examined using the Tali™ 
Image-based Cytometer (Life Technologies). The 
experiments were performed in triplicate. 
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Wound healing assay 
 
The cells were seeded in plastic 6-well plates 
until they reach confluence. Cells were scratch-
wounded with the aid of a sterile tip and treated 
with the dichloromethane fraction. The cells were 





The sample was filtered through 0.2 µm 
polyvinylidene difluoride (PVDF) filter (Millipore) 
to remove any particulate matter. Analysis was 
achieved using a HPLC (PerkinElmer) equipped 
with ultraviolet–visible detectors. 10 µL of the 
sample was injected and analyzed. The column 
used was C18 (250 × 4.6 mm) at a room 
temperature (25 ºC). The analysis was 
performed in a gradient system using a mixture 
of acetonitrile: water containing 0.5 % acetic acid 
as an eluent. 
 
The gradient program is depicted as shown in 
Table 1. 
 
Table 1: The gradient programme of the HPLC mobile 











0 5 0.5 70 30 0 
1 10 1 70 30 0 
2 10 1 30 70 1 




The cytotoxicity of the unrefined methanolic 
extract of Artemsia sieberia was examined in 
respect to Colo20, HCT116, DLD, MCF7, 
HepG2, Jurkat, and L929 cell lines, whereas the 
dichloromethane fraction was tested on just the 
MCF7 and HepG2 cell line. Initially, different 
concentrations of the unrefined methanolic 
extract of A. sieberia were used for the treatment 
of the seven cancer cell lines (between 50-500 
µg/mL). The LC50 values of the methanolic 
extract of A. sieberia against Colo20, HCT116, 
MCF7, Jurkat, HepG2, and L929 were 339.36, 
397.76, 333.01, 321.88, 161.50, and 322.73 
µg/mL respectively (Figure 1). The extract was 
less effective against the DLD cell line, however 
with the highest concentration demonstrating an 
inhibition of just 57.99 % inhibition. The most 
effective anticancer activity of the unrefined 
methanol extract was against HepG2 cell lines, 
which exhibited an LC50 value of 161.50 µg/mL. 
 













Concentration  (µg/ml)  
 
Figure.1: Cytotoxicity of crude methanol extract on 
different cancer cell lines. Values are mean ± SD (n = 
3). ■ COLO 20, □ HCTT 116, ▲L929, ◊ HEPG2, ▼ 
MCF7, ○ JURKAT 
 
To compare the cytotoxicity of the obtained 
fractions of A. sieberia aerial part extract, 
different concentrations ranged between 10-200 
µg/mL were used. The hexane and ethyl acetate 
fraction showed no antiproliferative activity but, 
the dichloromethane fraction exhibited the most 
antiproliferative effects on HepG2 and MCF7 cell 
lines. The IC50 values of this fraction against the 
HepG2 and MCF7 cell lines, after 24 h, were 
61.75 and 139.39 µg/mL respectively (Figure 2). 
The proliferation of cell lines tested for the 
unrefined methanolic extract and the partially 
purified dichloromethane fraction were found to 
be reduced in a dose dependent manner. 
 













Concentration  (µg/ml)  
 
Figure 2: Antiproliferative effect of the 
dichloromethane fraction on HepG2 and MCF7 cell 
lines after 24h of incubation. Values are mean ± SD (n 
= 3). ▼MCF7, ∆ HEPG2 
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In this study, assessment of apoptosis was 
performed by assessment of morphological and 
nuclear, changes as well as by Annexin V/PI 
double parameter assay were conducted. The 
morphology of the HepG2 cells was changed 
whereas the control cells were of normal cellular 
morphologies. Detachment, cellular integrity loss 
and shrinkage of cytoplasm were all observed in 
the treated HepG2 cells (data not shown). As 
shown in Figures 3A and3B, cells treated for 24 h 
with the dichloromethane fraction exhibited 
changes in the chromatin structure including 
fragmentation, even and even condensation and 
clustering against the nuclear border 
(arrowheads, Figure 3B). In contrast, the 
methanol control (Figure 3A) remained evenly 





Figure 3: Dichloromethane fraction caused apoptosis in HepG2 cells when stained with Hoechst 33258 and 
observed at 40X using fluorescence microscope. (A) Control (0.1% Methanol) cells; (B) treated cells (100 µg/mL). 
Apoptotic morphology was confirmed by nuclear condensation, and round apoptotic bodies (white arrows) 
 
Annexin V/PI staining is a sensitive technique for 
the detection of apoptosis. Cells were incubated 
with 120 µg/ml of dichloromethane fraction in a 
T25 flask. They were then harvested and stained 
using annexin-V/PI (propidium iodide). The cells 
were considered apoptotic if they were positive 
for  annexin-V and negative for propidium iodide. 
When the cells were positive for both the annexin 
V and propidium iodide, however they were 
determined to be dead cells. Similarly, when the 
cells were negative for both the annexin V and 
propidium iodide they were identified as viable 
cells. The treatment of HepG2 cells at 
concentrations of 120 µg/ml resulted in 
statistically significant apoptosis which appeared 
after 24 h with 49.6% inhibition using the 
dichloromethane fraction when compared with 





Figure 4: Viable, apoptotic and dead cells after treatment with the dichloromethane fraction at a concentration of 
120 µg/mL for 24 h. The results are illustrated as mean ± SD (n = 3); *** P < .001 in comparison to the untreated 
control group; ** p < 0.05 in comparison to the untreated control group 
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The wound healing assay investigated the ability 
of the dichloromethane fraction to suppress the 
migration of HepG2 cells in a denuded area at a 
concentration of 100 μg/ml and after incubation 
for 24 h. A reduction of cell migration was 
obtained by treatment with the dichloromethane 
fraction (Figure 5C-5D), while no migration was  
observed in the control untreated group (Figure 
5A-5B). 
 
HPLC fingerprint (Figure 6) of A. sieberia 
dichloromethane fraction revealed the presence 
of various constituents as evidenced by the 





Figure 5:  Dichloromethane fraction activity on the migration of HepG2 cells. Cells were scratch-wounded with a 
sterile tip and incubated with 100 µg/mL for 24 h, in control well (A,B) and the dichloromethane fraction treated 
well (C.D). The cells were photographed with phase-contrast microscopy using 40x objective 
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Although several investigations have been 
conducted in the control of cancer progression, 
still significant work is still required to develop 
and bypass drug resistance to existing drugs.  
Medicinal plants are a rich source of biological 
activity and played an indispensable role in 
cancer chemotherapy such as in the case of 
Vincristine and Vinblastine alkaloids isolated 
from Vinca rosea, in addition to Taxol isolated 
from Taxus brevifolia. 
 
The findings of the present study have revealaed 
that the unrefined methanolic extract of A. 
sieberia and its dichloromethane fraction affected 
HepG2 cell morphology dose dependently. The 
antiproliferative activity exhibited by the 
dichloromethane fraction can probably be 
attributed to its moderately polar compounds. 
 
This study was in agreement with the reports 
published by other researchers who have 
confirmed the cytotoxicity of the crude extract of 
A. sieberia. It has been reported that the total 
unrefined alcohol extract obtained from A. 
sieberia shows a potent inhibition against the 
murine mastocytoma cell line (P815) and the 
kidney carcinoma cell lines of hamsters (BSR) 
[11]. While, in another article, A. sieberia 
unrefined extract exhibited dose dependent 
antiproliferative activity against several cancer 
cell lines (human bladder carcinoma RT112, 
human laryngeal carcinoma and human 
myelogenous leukaemia K562), with IC50 = 
81.59, 59.05 and 90.96 µg/mL respectively [12]. 
The ethanol extract of A. sieberia significantly 
reduced HCT116 viability (IC50 of 51 mg/mL at 24 
h) in a dose dependent manner and induced 
apoptosis [13]. 
 
Induction of apoptosis has been documented as 
an indication for the development of an 
anticancer agent [14] because most 
chemotherapeutic drugs prompt cancer cell 
death through apoptosis [15]. One of the 
interesting outcomes of this study was induction 
of cell death through apoptosis by the 
dichloromethane fraction. Our results also 
revealed that the dichloromethane fraction of A. 
sieberia also induced apoptosis when analyzed 
by Annexin V/PI assay. This result was in 
accordance with the morphological studies.  
 
Metastasis is one of the key challenges for a 
successful cancer treatment [16] and the 
prevention of cancer metastasis is as important 
target for improving a patient’s prognosis. The 
use of the dichloromethane fraction of A. sieberia 
as a promising anticancer agent is strengthened 
by the wound healing assay the fraction exhibited 
against HepG2 cells. 
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The HPLC fingerprint of the A. sieberia 
dichloromethane fraction revealed the presence 
of various constituents, and this profile can be 
exploited for the purposed of identification, 
chemical characterization [19] and the quality 
control of herbal medicines complexity [20]. The 
HPLC profiles of the dichloromethane fraction of 
A. sieberia may enable drug companies to adjust 
the quantity of the fraction and thus help in the 
preparation of a standardized product. Additional 
investigations are required to isolate the active 
principle and explain the molecular mechanisms 
of dichloromethane fraction of A. sieberia in 




The dichloromethane fraction of A. sieberia 
caused cell membrane integrity damage, and 
initiated an apoptotic response in HepG2 cells. 
These results suggest that this dichloromethane 
fraction is a good candidate for the development 
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